# What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

> **NCT04590560** · NA · RECRUITING · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 60000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** screening for breast cancer with tomosynthesis and synthetic 2D mammography performed at different interval compared to actual clinical practice

## Key facts

- **NCT ID:** NCT04590560
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-06
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 60000 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590560, "What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04590560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*